Premium
Diagnostic accuracy and safety of short‐term teledermoscopic monitoring of atypical melanocytic lesions
Author(s) -
Berglund S.,
Bogren L.,
Paoli J.
Publication year - 2020
Publication title -
journal of the european academy of dermatology and venereology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.655
H-Index - 107
eISSN - 1468-3083
pISSN - 0926-9959
DOI - 10.1111/jdv.16144
Subject(s) - medicine , medical diagnosis , breslow thickness , observational study , retrospective cohort study , term (time) , melanoma , medical record , dermatology , surgery , radiology , pathology , cancer , sentinel lymph node , physics , quantum mechanics , cancer research , breast cancer
Background Short‐term dermoscopic monitoring ( STDM ) of atypical melanocytic lesions ( AML ) after 3.0–4.5 months can be used to detect featureless melanomas without performing countless unnecessary excisions of nevi. Recently, short‐term teledermoscopic monitoring ( STTM ) was incorporated into the STDM clinical routine at Sahlgrenska University Hospital in Gothenburg, Sweden. Follow‐up images for STTM were taken by an assistant nurse with subsequent teledermoscopic assessment by a dermatologist. Objectives The purpose of this study was to evaluate the diagnostic accuracy and safety of STTM . Methods In this retrospective observational study, data from electronic health records of patients with teledermoscopically monitored AML s were explored. The number of changed and excised AML s and their histopathological diagnoses were recorded. The excised AML s were categorized into three subgroups according to when they changed and were excised: (i) following STTM , (ii) after planned long‐term follow‐up or (iii) after unplanned long‐term follow‐up. Results A total of 686 patients with 883 AML s were monitored with STTM . Sixty‐two AML s (7.0%) were excised following STTM , 14 (1.6%) after planned long‐term follow‐up and 10 (1,1%) after unplanned long‐term follow‐up. Twenty‐one melanomas were detected using STTM , three after planned long‐term follow‐up and three after unplanned long‐term follow‐up. All melanomas were in situ ( n = 20) or thin and non‐ulcerated ( n = 7; median Breslow thickness 0.4 mm, range 0.3–0.8 mm). The sensitivity for the diagnosis of melanoma by means of STTM with the option of additional planned follow‐up was 88.9%, and the specificity was 93.9%. The number of AML s needed to monitor in order to detect one melanoma with the STTM routine was 32.7, and the number needed to excise was 3.2. Conclusions STTM of AML s was safe and allowed for high diagnostic accuracy. All detected melanomas were in situ or thin and non‐ulcerated. Furthermore, a considerable number of unnecessary excisions were spared.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom